RX
PrivateLast Round
Grant
Jul 1, 2026
Total Funding Raised
$2.39M
Momentum
Top 1%
of companies Caplight tracks
Company Overview
RX is a nuclear engineering company that specializes in Small Modular Reactor (SMR) design, licensing, and AI-powered plant solutions.
Sector
Energy & Sustainability
Verticals
Energy Management, Smart Grid, Renewable Energy, EV Charging
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
RX Comparables
Compare RX with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Camus Energy | 78% | |
| Oracle Solaris | 75% | |
| Mitsubishi Electric Corporation | 73% | |
RX Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jul 1, 2026 | ||||
| Accelerator | Apr 1, 2026 | ||||
| Pre Seed | Jan 1, 2026 | ||||
| Grant | Oct 1, 2024 | ||||
| Seed | Aug 1, 2024 | ||||
Grant | Apr 1, 2024 |
RX Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| CKD Venture Capital | Seed, Pre Seed |
| A Ventures | Seed, Pre Seed |
| Bluepoint Partners | Seed, Pre Seed |
| Company K Partners | Seed, Pre Seed |
| Banks Foundation for Young Entrepreneurs | Accelerator |
| KT Investment | Seed, Pre Seed |
| Mirae Asset Venture Investment | Seed, Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 18, 2026
Grew 500% QoQ from 1 to 6 employees.
- Jul 1, 2026
$14.5M grant from the Government of South Korea
RX Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about RX's valuation, stock price, and market status.